About Chiltern International
Chiltern International is a company based in United States founded in 1982 was acquired by LabCorp in September 2017. Chiltern International has completed 4 acquisitions, including Chiltern, Integrated Development Associates and Pacific Clinical Research. Chiltern International operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Berkshire County, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chiltern International Private Limited
- Date of Incorporation 01 Feb, 2005
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$422.73 K (USD)-72.17as on Mar 31, 2017
-
Net Profit
-$113.34 K (USD)-148.16as on Mar 31, 2017
-
EBITDA
-$113.71 K (USD)-237.27as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
LabCorp
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Chiltern
& 3 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chiltern International
Investors in Chiltern International
Chiltern International has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Kester Capital and Czura Thornton.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kester Capital is focused on private equity investments in technology and life sciences sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for Chiltern International
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chiltern International
Chiltern International has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Chiltern, Integrated Development Associates and Pacific Clinical Research.
Investment portfolio details for Chiltern International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical trial management services are provided across Asian markets.
|
Locked | Locked | 2009 | Locked | |
|
Full-service CRO, based out of Japan and Asia and also offering regulatory consulting services
|
Locked | Locked | 2004 | Locked | |
|
Full-service oncology CRO operations are conducted globally.
|
Locked | Locked | 1986 | Locked |
Complete acquisition details for Chiltern International
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Chiltern International
Detailed financials for Chiltern International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chiltern International Comparisons
Peer comparison for Chiltern International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chiltern International
Chiltern International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
Detailed competitors of Chiltern International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chiltern International
Complete news archive for Chiltern International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiltern International
Chiltern International was founded in 1982 and raised its 1st funding round 28 years after it was founded.
Chiltern International is headquartered in United States. It is registered at Massachusetts, United States.
Annual revenue of Chiltern International is $422.73K as on Mar 31, 2017.
Chiltern is a full-service CRO focussed on providing clinical research development services in a variety of specialty areas and engagement models for biotech, pharma, biopharma, medical device and diagnostics industries. It provides a suite of services in clinical development, medical scientific affairs, data analysis, pharmacovigilance, strategic regulatory and clinical supplies. It is currently operating in 47 countries with 22,000 investigation sites claims to have conducted 1,800clinical trials. Chilterns offerings are focused on three major areas - Chiltern Oncology (Oncology CRO services across all phases of development), Chiltern Biopharmaceutics (Global CRO services with therapeutic experience in respiratory, ophthalmology, infectious disease, vaccines and dermatology) , Chiltern Source (Functional Services and Sourcing solutions specializing in customized sourcing solutions for clinical, regulatory, medical and biometrics services.
Chiltern International's top competitors include Emmes, Syneos Health and ClinChoice.
Chiltern International has made 4 acquisitions, including Chiltern, Integrated Development Associates, and Pacific Clinical Research.
Chiltern International has 3 investors. Key investors include LabCorp, Kester Capital, and Czura Thornton.